-
1
-
-
20144375961
-
In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis
-
DOI 10.1080/00498250500087671
-
Ansede JH, Voyksner RD, Ismail MA, Boykin DW, Tidwell RR, and Hall JE (2005) In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis. Xenobiotica 35:211-226. (Pubitemid 40776556)
-
(2005)
Xenobiotica
, vol.35
, Issue.3
, pp. 211-226
-
-
Ansede, J.H.1
Voyksner, R.D.2
Ismail, M.A.3
Boykin, D.W.4
Tidwell, R.R.5
Hall, J.E.6
-
2
-
-
67849132418
-
Metabolites of the phenylurea herbicides chlorotoluron, diuron, isoproturon and linuron produced by the soil fungus mortierella sp
-
Badawi N, Rønhede S, Olsson S, Kragelund BB, Johnsen AH, Jacobsen OS, and Aamand J (2009) Metabolites of the phenylurea herbicides chlorotoluron, diuron, isoproturon and linuron produced by the soil fungus Mortierella sp. Environ Pollut 157:2806-2812.
-
(2009)
Environ Pollut
, vol.157
, pp. 2806-2812
-
-
Badawi, N.1
Rønhede, S.2
Olsson, S.3
Kragelund, B.B.4
Johnsen, A.H.5
Jacobsen, O.S.6
Aamand, J.7
-
3
-
-
60749084392
-
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine médecins sans frontières programmes
-
Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME, and Checchi F (2009) Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg 103:280-290.
-
(2009)
Trans R Soc Trop Med Hyg
, vol.103
, pp. 280-290
-
-
Balasegaram, M.1
Young, H.2
Chappuis, F.3
Priotto, G.4
Raguenaud, M.E.5
Checchi, F.6
-
4
-
-
35548959525
-
Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease
-
DOI 10.1038/sj.bjp.0707354, PII 0707354
-
Barrett MP, Boykin DW, Brun R, and Tidwell RR (2007) Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol 152:1155-1171. (Pubitemid 350242432)
-
(2007)
British Journal of Pharmacology
, vol.152
, Issue.8
, pp. 1155-1171
-
-
Barrett, M.P.1
Boykin, D.W.2
Brun, R.3
Tidwell, R.R.4
-
5
-
-
0031925910
-
Parameters influencing biotransformation rates of Phenylurea herbicides by soil microorganisms
-
DOI 10.1006/pest.1998.2324
-
Berger B (1998) Parameters influencing biotransformation rates of phenylurea herbicides by soil microorganisms. Pestic Biochem Physiol 60:71-82. (Pubitemid 28343934)
-
(1998)
Pesticide Biochemistry and Physiology
, vol.60
, Issue.2
, pp. 71-82
-
-
Berger, B.M.1
-
6
-
-
0028956777
-
Dicationic diarylfurans as anti-pneumocystis carinii agents
-
Boykin DW, Kumar A, Spychala J, Zhou M, Lombardy RJ, Wilson WD, Dykstra CC, Jones SK, Hall JE, and Tidwell RR,, et al. (1995) Dicationic diarylfurans as anti-Pneumocystis carinii agents. J Med Chem 38:912-916.
-
(1995)
J Med Chem
, vol.38
, pp. 912-916
-
-
Boykin, D.W.1
Kumar, A.2
Spychala, J.3
Zhou, M.4
Lombardy, R.J.5
Wilson, W.D.6
Dykstra, C.C.7
Jones, S.K.8
Hall, J.E.9
Tidwell, R.R.10
-
7
-
-
3542995726
-
The complexities of hepatic drug transport: Current knowledge and emerging concepts
-
DOI 10.1023/B:PHAM.0000026420.79421.8f
-
Chandra P and Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719-735. (Pubitemid 39011292)
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.5
, pp. 719-735
-
-
Chandra, P.1
Brouwer, K.L.R.2
-
8
-
-
27544492348
-
Hepatic, extrahepatic, microsomal, and mitochondrial activation of the n-hydroxylated prodrugs benzamidoxime, guanoxabenz, and ro 48-3656 ([[1-[(2s)2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4- piperidinyl]oxy]-acetic acid
-
Clement B, Mau S, Deters S, and Havemeyer A (2005) Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino) iminomethyl]benzoyl]amino]-1-oxopropyl]-4- piperidinyl]oxy]-acetic acid). Drug Metab Dispos 33:1740-1747.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 1740-1747
-
-
Clement, B.1
Mau, S.2
Deters, S.3
Havemeyer, A.4
-
9
-
-
34249074813
-
Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists
-
DOI 10.1007/s11095-007-9239-y
-
Gong Y, Zhao Z, McConn DJ, Beaudet B, Tallman M, Speake JD, Ignar DM, and Krise JP (2007) Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists. Pharm Res 24:1138-1144. (Pubitemid 46798893)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.6
, pp. 1138-1144
-
-
Gong, Y.1
Zhao, Z.2
McConn, D.J.3
Beaudet, B.4
Tallman, M.5
Speake, J.D.6
Ignar, D.M.7
Krise, J.P.8
-
10
-
-
33845952893
-
Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme
-
DOI 10.1074/jbc.M607697200
-
Havemeyer A, Bittner F, Wollers S, Mendel R, Kunze T, and Clement B (2006) Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J Biol Chem 281:34796-34802. (Pubitemid 46036518)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.46
, pp. 34796-34802
-
-
Havemeyer, A.1
Bittner, F.2
Wollers, S.3
Mendel, R.4
Kunze, T.5
Clement, B.6
-
11
-
-
33751530074
-
15N-labelled 2,5-Bis[5-amidino-2- pyridyl]furan and 2,5-Bis[5-(methoxyamidino)-2-pyridyl]furan
-
DOI 10.1002/jlcr.1111
-
Ismail MA and Boykin DW (2006) Synthesis of deuterium and 15N-labelled 2,5-Bis[5-amidino-2- pyridyl]furan and 2,5-Bis[5-(methoxyamidino)-2-pyridyl] furan. J Label Compd Radiopharm 49:985-996. (Pubitemid 44831285)
-
(2006)
Journal of Labelled Compounds and Radiopharmaceuticals
, vol.49
, Issue.11
, pp. 985-996
-
-
Ismail, M.A.1
Boykin, D.W.2
-
12
-
-
0142028913
-
Synthesis and antiprotozoal activity of aza-analogues of furamidine
-
DOI 10.1021/jm0302602
-
Ismail MA, Brun R, Easterbrook JD, Tanious FA, Wilson WD, and Boykin DW (2003) Synthesis and antiprotozoal activity of aza-analogues of furamidine. J Med Chem 46:4761-4769. (Pubitemid 37271624)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.22
, pp. 4761-4769
-
-
Ismail, M.A.1
Brun, R.2
Easterbrook, J.D.3
Tanious, F.A.4
Wilson, W.D.5
Boykin, D.W.6
-
13
-
-
18844369894
-
Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
-
DOI 10.1124/dmd.104.003715
-
Ito K, Hallifax D, Obach RS, and Houston JB (2005) Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm. Drug Metab Dispos 33:837-844. (Pubitemid 40686638)
-
(2005)
Drug Metabolism and Disposition
, vol.33
, Issue.6
, pp. 837-844
-
-
Ito, K.1
Hallifax, D.2
Obach, R.S.3
Houston, J.B.4
-
14
-
-
34247490248
-
Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications
-
DOI 10.1002/jps.20792
-
Kaufmann AM and Krise JP (2007) Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci 96:729-746. (Pubitemid 46657864)
-
(2007)
Journal of Pharmaceutical Sciences
, vol.96
, Issue.4
, pp. 729-746
-
-
Kaufmann, A.M.1
Krise, J.P.2
-
15
-
-
0030763543
-
Drug metabolism in hepatocyte sandwich cultures of rats and humans
-
DOI 10.1016/S0006-2952(97)00204-9, PII S0006295297002049
-
Kern A, Bader A, Pichlmayr R, and Sewing KF (1997) Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem Pharmacol 54:761-772. (Pubitemid 27404677)
-
(1997)
Biochemical Pharmacology
, vol.54
, Issue.7
, pp. 761-772
-
-
Kern, A.1
Bader, A.2
Pichlmayr, R.3
Sewing, K.-F.4
-
16
-
-
0036297916
-
Treatment of human African trypanosomiasis - Present situation and needs for research and development
-
DOI 10.1016/S1473-3099(02)00321-3
-
Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin J, and Büscher P (2002) Treatment of human African trypanosomiasis: present situation and needs for research and development. Lancet Infect Dis 2:437-440. (Pubitemid 34693262)
-
(2002)
Lancet Infectious Diseases
, vol.2
, Issue.7
, pp. 437-440
-
-
Legros, D.1
Ollivier, G.2
Gastellu-Etchegorry, M.3
Paquet, C.4
Burri, C.5
Jannin, J.6
Buscher, P.7
-
17
-
-
1342328134
-
Antigenic variation in African trypanosomes: Monitoring progress
-
DOI 10.1016/j.pt.2003.12.004
-
McCulloch R (2004) Antigenic variation in African trypanosomes: monitoring progress. Trends Parasitol 20:117-121. (Pubitemid 38264443)
-
(2004)
Trends in Parasitology
, vol.20
, Issue.3
, pp. 117-121
-
-
McCulloch, R.1
-
18
-
-
0019579579
-
Autocatalytic alkylation of the cytochrome p-450 prosthetic haem group by 1-aminobenzotriazole: Isolation of an nn-bridged benzyneprotoporphyrin ix adduct
-
Ortiz de Montellano PR and Mathews JM (1981) Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole: isolation of an NN-bridged benzyneprotoporphyrin IX adduct. Biochem J 195:761-764.
-
(1981)
Biochem J
, vol.195
, pp. 761-764
-
-
Ortiz De Montellano, P.R.1
Mathews, J.M.2
-
19
-
-
77954970164
-
Diamidines for human african trypanosomiasis
-
Paine MF, Wang MZ, Generaux CN, Boykin DW, Wilson WD, De Koning HP, Olson CA, Pohlig G, Burri C, and Brun R, et al. (2010) Diamidines for human African trypanosomiasis. Curr Opin Investig Drugs 11:876-883.
-
(2010)
Curr Opin Investig Drugs
, vol.11
, pp. 876-883
-
-
Paine, M.F.1
Wang, M.Z.2
Generaux, C.N.3
Boykin, D.W.4
Wilson, W.D.5
De Koning, H.P.6
Olson, C.A.7
Pohlig, G.8
Burri, C.9
Brun, R.10
-
20
-
-
67649635323
-
Nifurtimox-eflornithine combination therapy for second-stage african trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase iii, non-inferiority trial
-
Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, and Kazadi-Kyanza S,, et al. (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374:56-64.
-
(2009)
Lancet
, vol.374
, pp. 56-64
-
-
Priotto, G.1
Kasparian, S.2
Mutombo, W.3
Ngouama, D.4
Ghorashian, S.5
Arnold, U.6
Ghabri, S.7
Baudin, E.8
Buard, V.9
Kazadi-Kyanza, S.10
-
21
-
-
41849114583
-
Cooperativity in oxidation reactions catalyzed by cytochrome p450 1a2: Highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding
-
Sohl CD, Isin EM, Eoff RL, Marsch GA, Stec DF, and Guengerich FP (2008) Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding. J Biol Chem 283:7293-7308.
-
(2008)
J Biol Chem
, vol.283
, pp. 7293-7308
-
-
Sohl, C.D.1
Isin, E.M.2
Eoff, R.L.3
Marsch, G.A.4
Stec, D.F.5
Guengerich, F.P.6
-
22
-
-
16244410117
-
Human African trypanosomiasis: Clinical presentation and immune response
-
DOI 10.1111/j.0141-9838.2004.00731.x
-
Sternberg JM (2004) Human African trypanosomiasis: clinical presentation and immune response. Parasite Immunol 26:469-476. (Pubitemid 40461163)
-
(2004)
Parasite Immunology
, vol.26
, Issue.11-12
, pp. 469-476
-
-
Sternberg, J.M.1
-
23
-
-
33751543062
-
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4- amidinophenyl)furan-bis-O-methylamidoxime]
-
DOI 10.1124/dmd.106.010587
-
Wang MZ, Saulter JY, Usuki E, Cheung YL, Hall M, Bridges AS, Loewen G, Parkinson OT, Stephens CE, and Allen JL, et al. (2006) CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O- methylamidoxime] 2,5-bis 4-amidinophenyl furan-bis- O-methylamidoxime Drug Metab Dispos 34:1985-1994. (Pubitemid 44837759)
-
(2006)
Drug Metabolism and Disposition
, vol.34
, Issue.12
, pp. 1985-1994
-
-
Wang, M.Z.1
Saulter, J.Y.2
Usuki, E.3
Cheung, Y.-L.4
Hall, M.5
Bridges, A.S.6
Loewen, G.7
Parkinson, O.T.8
Stephens, C.E.9
Allen, J.L.10
Zeldin, D.C.11
Boykin, D.W.12
Tidwell, R.R.13
Parkinson, A.14
Paine, M.F.15
Hall, J.E.16
-
24
-
-
70349334612
-
New treatment option for second-stage african sleeping sickness: In vitro and in vivo efficacy of aza analogs of db289
-
Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, and Brun R (2009) New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 53:4185-4192.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4185-4192
-
-
Wenzler, T.1
Boykin, D.W.2
Ismail, M.A.3
Hall, J.E.4
Tidwell, R.R.5
Brun, R.6
-
25
-
-
74549117722
-
A new classification of prodrugs: Regulatory perspectives
-
Wu K-M (2009) A new classification of prodrugs: regulatory perspectives. Pharmaceuticals 2: 77-81.
-
(2009)
Pharmaceuticals
, vol.2
, pp. 77-81
-
-
Wu, K.-M.1
-
26
-
-
34248669587
-
Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology
-
DOI 10.1016/j.tox.2007.04.005, PII S0300483X07002120
-
Wu KM and Farrelly JG (2007) Regulatory perspectives of type II prodrug development and time-dependent toxicity management: nonclinical pharm/tox analysis and the role of comparative toxicology. Toxicology 236:1-6. (Pubitemid 46777073)
-
(2007)
Toxicology
, vol.236
, Issue.1-2
, pp. 1-6
-
-
Wu, K.-M.1
Farrelly, J.G.2
-
27
-
-
1342323347
-
Catalytic Activity and Isoform-Specific Inhibition of Rat Cytochrome P450 4F Enzymes
-
DOI 10.1124/jpet.103.059626
-
Xu F, Falck JR, Ortiz de Montellano PR, and Kroetz DL (2004) Catalytic activity and isoformspecific inhibition of rat cytochrome P450 4F enzymes. J Pharmacol Exp Ther 308:887-95. (Pubitemid 38263962)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.308
, Issue.3
, pp. 887-895
-
-
Xu, F.1
Falck, J.R.2
Ortiz De Montellano, P.R.3
Kroetz, D.L.4
-
28
-
-
0036447583
-
5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli
-
DOI 10.1006/prep.2001.1578
-
Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, and Nakajima M,, et al. (2002) Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24: 329-337. (Pubitemid 35420057)
-
(2002)
Protein Expression and Purification
, vol.24
, Issue.3
, pp. 329-337
-
-
Yamazaki, H.1
Nakamura, M.2
Komatsu, T.3
Ohyama, K.4
Hatanaka, N.5
Asahi, S.6
Shimada, N.7
Guengerich, F.P.8
Shimada, T.9
Nakajima, M.10
Yokoi, T.11
-
29
-
-
79955021414
-
Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: Comparison of two preclinical hepatic models
-
Yan GZ, Brouwer KL, Pollack GM, Wang MZ, Tidwell RR, Hall JE, and Paine MF (2011) Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models. J Pharmacol Exp Ther 337:503-512.
-
(2011)
J Pharmacol Exp Ther
, vol.337
, pp. 503-512
-
-
Yan, G.Z.1
Brouwer, K.L.2
Pollack, G.M.3
Wang, M.Z.4
Tidwell, R.R.5
Hall, J.E.6
Paine, M.F.7
-
30
-
-
0036845742
-
Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl) furan across Caco-2 cell monolayers via its methylamidoxime prodrug
-
DOI 10.1023/A:1020957430400
-
Zhou L, Lee K, Thakker DR, Boykin DW, Tidwell RR, and Hall JE (2002) Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug. Pharm Res 19:1689-1695. (Pubitemid 35305521)
-
(2002)
Pharmaceutical Research
, vol.19
, Issue.11
, pp. 1689-1695
-
-
Zhou, L.1
Lee, K.2
Thakker, D.R.3
Boykin, D.W.4
Tidwell, R.R.5
Hall, J.E.6
-
31
-
-
1942516882
-
Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry
-
DOI 10.1002/jms.591
-
Zhou L, Thakker DR, Voyksner RD, Anbazhagan M, Boykin DW, Hall JE, and Tidwell RR (2004) Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furanbis- O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 39:351-360. (Pubitemid 38515348)
-
(2004)
Journal of Mass Spectrometry
, vol.39
, Issue.4
, pp. 351-360
-
-
Zhou, L.1
Thakker, D.R.2
Voyksner, R.D.3
Anbazhagan, M.4
Boykin, D.W.5
Hall, J.E.6
Tidwell, R.R.7
|